Skip to main content
OpenTrials
Completed

NCT Number: NCT06815523

Prediction of Duration of Mechanical Ventilation in Acute Hypoxemic Respiratoty Failure

Acute hypoxemic respiratory failure (AHRF) is a common cause of admission in intensive care units (ICUs) worldwide. We will assess machine learning (ML) techniques for prediction of prolonged duration (> or = to 7 days) of mechanical ventilation (MV) in 1,241 patients enrolled in the PANDORA study in Spain. The study was registered with ClinalTrials.gov (NCT03145974). Our aim is to identify a model with the minimum number of variables that predict duration of prolonged ventilation in AHRF patients using data as early as from the first 48 hours with machine learning algorithms.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Dr. Negrin, Las Palmas de Gran Canaria, Las Palmas, Spain

Loading trial locations.

About this study

Acute hypoxemic respiratory failure (AHRF) is the most common cause of admission in intensive care units (ICUs) worldwide. The investigators will assess the value of machine learning (ML) techniques for prediction of prolonged duration (> or equeal to 7 days) of mechanical ventilation (MV) in 1,241 patients enrolled in the PANDORA study in Spain. Few studies have investigated the prediction of prolonged MV in patients with AHRF.

For model training and testing, the investigators will extract data from random pateints from the first 2 days after diagnosis of AHRF. The investigators had a database with 2,000,000 anonymized and dissociated demographics and clinically relevant data from 1,241 patients with AHRF from 22 hospitals in Spain. The investigators will follow the TRIPOD guidelines for prediction models. The investigators will screen relevant collected variables using a genetic algorithm variable selection to achieve parsimony. We will use 5-fold corss-validation in the data set of patients with data at T0, T24 and T48. We will use 25% of patients randomly selected for evaluation of the model.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • enotracheal intubation puls mechanical ventilation
  • PaO2/FiO2 ratio <or = 300 mmHg under MV with PEEP >or =5 and FiO2 >or = 0.3

Exclusion criteria

  • Brain death patients

Treatment and study plan

Machine learning and logistic regression for the training/testing cohort and validation cohort

Other

Machine learning and logistic regression for the validation cohort

Primary outcomes

  1. MV duration

    Time frame: up to 100 weeks

    duration of mechanical ventilation

Sponsors and collaborators

Lead sponsor

Jesus Villar

Other

Collaborators

  • Hospital Universitario de Gran Canaria Doctor Negrín
  • Instituto de Salud Carlos III

Registry information

Official study title

Prediction of Duration of Mechanical Venylation in Patients Wit Acute Hypoxemic Respiratory Failure Usinf Machine Learning Approaches

Acronym: PREMIER

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Feb 7, 2025
Registry last updated
Jul 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.